Yokukansan (TJ-54) for treatment of pervasive developmental disorder not otherwise specified and Asperger's disorder: a 12-week prospective, open-label study

number of downloads : ?

Use this link to cite this item : https://ir.lib.shimane-u.ac.jp/53803

language	eng
Author	Miyaoka Tsuyoshi Department of Psychiatry, Shimane University School of Medicine, 89-1 Enyacho, Izumo, 693-8501, Japan Wake, Rei Furuya Motohide Department of Psychiatry, Shimane University School of Medicine, 89-1 Enyacho, Izumo, 693-8501, Japan Liaury Kristian Department of Psychiatry, Shimane University School of Medicine, 89-1 Enyacho, Izumo, 693-8501, Japan Ieda Masa Department of Psychiatry, Shimane University School of Medicine, 89-1 Enyacho, Izumo, 693-8501, Japan Kawakami Kazunori Department of Psychiatry, Shimane University School of Medicine, 89-1 Enyacho, Izumo, 693-8501, Japan TSUCHIE, Keiko Inagaki, Takuji Horiguchi Jun Department of Psychiatry, Shimane University School of Medicine, 89-1 Enyacho, Izumo, 693-8501, Japan
Subject	Pervasive developmental disorder not otherwise specified; Asperger's disorder; Irritability; Yokukansan (TJ-54)
Journal Title	BMC PSYCHIATRY
Volume	12
ISSN	1471-244X
Published Date	2012-11-29
DOI	10.1186/1471-244X-12-215
PubMed ID	23194148
Publisher	BIOMED CENTRAL LTD
NII Type	Journal Article
OAI-PMH Set	Faculty of Medicine
Remark	Part of this work was supported by Grant-in-Aid for Scientific Research on Priority Areas No. 13770544 and 50284047 from the Ministry of Education, Science, Sports and Culture of Japan, and 012 from the Ministry of Health Labour Sciences Research Grant of Japan.